TABLE 1.
Characteristic | NSAID Exposure | No NSAID Exposure | Comparison | ||||||
---|---|---|---|---|---|---|---|---|---|
N | Mean | SD | N | Mean | SD | t | df | p | |
Age (years) | 1,245 | 53.0 | 15.3 | 283 | 46.9 | 17.6 | 5.4 | 1526 | <0.001 |
Body mass index (kg/m2) | 991 | 32.5 | 8.2 | 171 | 28.2 | 7.1 | 7.1 | 1160 | <0.001 |
N | % | N | % | χ 2 | df | p | |||
Female | 914 | 73 | 175 | 62 | 14.5 | 1 | <0.001 | ||
Race/ethnicitya | 46.6 | 4 | <0.001 | ||||||
White | 841 | 68 | 236 | 83 | |||||
African American | 92 | 7 | 8 | 3 | |||||
Hispanic | 272 | 22 | 21 | 7 | |||||
Asian | 14 | 1 | 6 | 2 | |||||
Other | 26 | 2 | 12 | 4 | |||||
Insurance | 57.7 | 2 | <0.001 | ||||||
Public | 651 | 52 | 85 | 30 | |||||
Private | 558 | 45 | 176 | 62 | |||||
Other/unknown | 36 | 3 | 22 | 8 | |||||
Comorbidity | |||||||||
History of hypertension | 693 | 56 | 80 | 28 | 68.1 | 1 | <0.001 | ||
History of hyperlipidemia | 777 | 62 | 101 | 36 | 66.3 | 1 | <0.001 | ||
History of myocardial infarction |
114 | 9 | 2 | 1 | 22.3 | 1 | <0.001 | ||
History of stroke | 167 | 13 | 9 | 3 | 22.7 | 1 | <0.001 | ||
History of type 2 diabetes | 371 | 30 | 26 | 9 | 49.9 | 1 | <0.001 | ||
NSAID and NSAID-like treatment |
|||||||||
NSAIDs | 1,037 | 83 | |||||||
COX-2 inhibitors | 202 | 16 | |||||||
Salicylates | 564 | 45 | |||||||
NSAIDs or COX-2 inhibitors or salicylatesb |
1,245 | 100 | |||||||
NSAIDs and COX-2 inhibitors | 171 | 14 | |||||||
NSAIDs and salicylates | 444 | 36 | |||||||
COX-2 inhibitors and salicylates |
126 | 10 | |||||||
NSAIDs and COX-2 inhibitors and salicylates |
111 | 9 | |||||||
Antidepressant treatment response |
|||||||||
Resistant | 586 | 47 | 103 | 36 | 10.2 | 1 | 0.001 | ||
Responsive | 659 | 53 | 180 | 64 | |||||
N | Median | Interquartile Range |
N | Median | Interquartile Range |
Kruskal-Wallis Nonparametric Statistic |
df | p | |
Health care utilization | |||||||||
Medical facts recorded | 1,245 | 639 | 665 | 283 | 228 | 280 | 286754 | 1 | <0.001 |
Psychiatry visits | |||||||||
All psychiatric visits | 1,245 | 12 | 17 | 283 | 9 | 14 | 196625 | 1 | <0.001 |
Depressed visits | 1,245 | 2 | 6 | 283 | 1 | 4 | 206820 | 1 | <0.001 |
Well visits | 1,245 | 1 | 5 | 283 | 2 | 4 | 160643 | 1 | <0.001 |
Antidepressant treatment | |||||||||
Unique antidepressants | 1,245 | 3 | 3 | 283 | 2 | 2 | 235580 | 1 | <0.001 |
Refills per antidepressant | 1,245 | 7 | 15 | 283 | 3 | 8 | 229724 | 1 | <0.001 |
Comorbidity | |||||||||
Age-adjusted Charlson comorbidity index |
1,245 | 6 | 6 | 283 | 2 | 5 | 245851 | 1 | <0.001 |
Data on race and ethnicity were collected using a single field in the electronic medical records; individuals who identified as Hispanic are not further characterized.
Analysis is consistent with that of Warner-Schmidt et al. (3).